CN1543995A - Psoriasis treating ointment - Google Patents
Psoriasis treating ointment Download PDFInfo
- Publication number
- CN1543995A CN1543995A CNA2003101055037A CN200310105503A CN1543995A CN 1543995 A CN1543995 A CN 1543995A CN A2003101055037 A CNA2003101055037 A CN A2003101055037A CN 200310105503 A CN200310105503 A CN 200310105503A CN 1543995 A CN1543995 A CN 1543995A
- Authority
- CN
- China
- Prior art keywords
- radix
- radix angelicae
- cortex
- flos carthami
- rhizoma chuanxiong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an ointment for treating psoriasis, wherein the compositions by weight portion are Chinese angelica root 2-8, dahurian angelica root 3-10, safflower 3-12, Chinese dittany bark 2-6, Ligusticum wallichii 2-10, dyers woad leaf 2-10, cortex acanthopanacis 2-8, prepared rehmannia root 2-8, panicled swallowwort root 1-8, alkanna tinctoria 3-12, aromatic oil 500-1500 and beeswax 20-100.
Description
Technical field
The present invention relates to treat psoriasis external used medicine technical field.
Background technology
Psoriasis is a kind of skin class difficult and complicated illness, is mainly in patient's head and extremity, and severe patient spreads all over each position of whole body.This disease not only has a strong impact on patient's skin appearance, and pruritus is in various degree arranged, and it is many-sided giving the misery that the patient caused.At present, mostly adopt for this sick conventional Therapeutic Method clinically have sterilization, the medicine of antipruritic, softening the hard mass, the effect of invigorating blood circulation, but this disease is not due to the general pathogenic bacteria, if be not to be difficult to effectively suppress this pathogenic bacteria from take good care of QI and blood at all, moreover, be that certain toxic and side effects is arranged if be used for conventional medicine for a long time.
Summary of the invention
The purpose of this invention is to provide a kind of treatment psoriasis cream, the QI and blood of can't fundamentally taking good care of that it can solve the prior art existence suppresses the psoriasis bacterium, and the problem with certain toxic and side effects.
The objective of the invention is to be achieved through the following technical solutions: treatment psoriasis ointment is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 2-8, Radix Angelicae Dahuricae 3-10, Flos Carthami 3-12, Cortex Dictamni 2-6, Rhizoma Chuanxiong 2-10, Folium Isatidis 2-10, Cortex Acanthopancis 2-8, Radix Rehmanniae Preparata 2-8, Radix Cynanchi Paniculati 1-8, Radix Arnebiae (Radix Lithospermi) 3-12, Oleum sesami 500-1500, Cera Flava 20-100.
For further realizing purpose of the present invention, also can finish by the following technical programs: described treatment psoriasis ointment, it comprises following component (in weight portion): Radix Angelicae Sinensis 3-7, Radix Angelicae Dahuricae 4-9, Flos Carthami 4-10, Cortex Dictamni 2.5-5.5, Rhizoma Chuanxiong 3-9, Folium Isatidis 3-9, Cortex Acanthopancis 3-7, Radix Rehmanniae Preparata 3-7, Radix Cynanchi Paniculati 2-7, Radix Arnebiae (Radix Lithospermi) 4-10, Oleum sesami 700-1400, Cera Flava 30-80.Described treatment psoriasis ointment, it comprises following component (in weight portion): Radix Angelicae Sinensis 3.5-6.5, Radix Angelicae Dahuricae 4.5-8, Flos Carthami 5-9, Cortex Dictamni 3-5, Rhizoma Chuanxiong 4-8, Folium Isatidis 4-8, Cortex Acanthopancis 3.5-6.5, Radix Rehmanniae Preparata 3.5-6.5, Radix Cynanchi Paniculati 3-6, Radix Arnebiae (Radix Lithospermi) 5-8, Oleum sesami 800-1300, Cera Flava 40-70.Described treatment psoriasis ointment, it comprises following component (in weight portion): Radix Angelicae Sinensis 4-6, Radix Angelicae Dahuricae 5-7, Flos Carthami 6-8, Cortex Dictamni 3.5-4.5, Rhizoma Chuanxiong 5-7, Folium Isatidis 5-7, Cortex Acanthopancis 4-6, Radix Rehmanniae Preparata 4-6, Radix Cynanchi Paniculati 3-5, Radix Arnebiae (Radix Lithospermi) 6-8, Oleum sesami 900-1100, Cera Flava 50-65.Described treatment psoriasis ointment, it comprises following component (in weight portion): Radix Angelicae Sinensis 4.5-5.5, Radix Angelicae Dahuricae 5.5-6.5, Flos Carthami 6.5-7.5, Cortex Dictamni 3.8-4.2, Rhizoma Chuanxiong 5.5-6.5, Folium Isatidis 5.5-6.5, Cortex Acanthopancis 4.5-5.5, Radix Rehmanniae Preparata 4.5-5.5, Radix Cynanchi Paniculati 3.5-4.5, Radix Arnebiae (Radix Lithospermi) 6.5-7.5, Oleum sesami 950-1050, Cera Flava 55-62.Described treatment psoriasis ointment, it comprises following component (in weight portion): Radix Angelicae Sinensis 5, the Radix Angelicae Dahuricae 6, Flos Carthami 7, Cortex Dictamni 4, Rhizoma Chuanxiong 6, Folium Isatidis 6, Cortex Acanthopancis 5, Radix Rehmanniae Preparata 5, Radix Cynanchi Paniculati 4, Radix Arnebiae (Radix Lithospermi) 7, Oleum sesami 1000, Cera Flava 60.
Beneficial effect of the present invention: the Chinese medicinal ointment that contains Oleum sesami because of employing is as the skin care medicine, and will have the QI and blood of taking good care of and can effectively suppress Chinese herbal medicine such as Radix Angelicae Sinensis, Cortex Acanthopancis, Flos Carthami, the Folium Isatidis combination of pathogenic bacteria through scientific composition, it can fundamentally cure this disease, through the research experiment curative effect is more remarkable for many years, non-relapse after healing.
The specific embodiment
Embodiment 1 (g of unit):
Get Radix Angelicae Sinensis 8, the Radix Angelicae Dahuricae 10, Flos Carthami 12, Cortex Dictamni 6, Rhizoma Chuanxiong 10, Folium Isatidis 10, Cortex Acanthopancis 8, Radix Rehmanniae Preparata 8, Radix Cynanchi Paniculati 8, Radix Arnebiae (Radix Lithospermi) 12, Oleum sesami 1500, Cera Flava 100, the invention of preparation technology's cost of manufacture gets final product routinely.
Embodiment 2 (g of unit):
Get Radix Angelicae Sinensis 2, the Radix Angelicae Dahuricae 3, Flos Carthami 3, Cortex Dictamni 2, Rhizoma Chuanxiong 2, Folium Isatidis 2, Cortex Acanthopancis 2, Radix Rehmanniae Preparata 2, Radix Cynanchi Paniculati 1, Radix Arnebiae (Radix Lithospermi) 3, Oleum sesami 500, Cera Flava 20, the invention of preparation technology's cost of manufacture gets final product routinely.
Embodiment 3 (g of unit):
Get Radix Angelicae Sinensis 4, the Radix Angelicae Dahuricae 5, Flos Carthami 6, Cortex Dictamni 3.5, Rhizoma Chuanxiong 5, Folium Isatidis 5, Cortex Acanthopancis 4, Radix Rehmanniae Preparata 4, Radix Cynanchi Paniculati 3, Radix Arnebiae (Radix Lithospermi) 6, Oleum sesami 900, Cera Flava 50, the invention of preparation technology's cost of manufacture gets final product routinely.
Embodiment 4 (g of unit):
Get Radix Angelicae Sinensis 5.5, the Radix Angelicae Dahuricae 6.5, Flos Carthami 7.5, Cortex Dictamni 4.2, Rhizoma Chuanxiong 6.5, Folium Isatidis 6.5, Cortex Acanthopancis 5.5, Radix Rehmanniae Preparata 5.5, Radix Cynanchi Paniculati 4.5, Radix Arnebiae (Radix Lithospermi) 7.5, Oleum sesami 1050, Cera Flava 62, the invention of preparation technology's cost of manufacture gets final product routinely.
Embodiment 5 (g of unit):
Get Radix Angelicae Sinensis 5, the Radix Angelicae Dahuricae 6, Flos Carthami 7, Cortex Dictamni 4, Rhizoma Chuanxiong 6, Folium Isatidis 6, Cortex Acanthopancis 5, Radix Rehmanniae Preparata 5, Radix Cynanchi Paniculati 4, Radix Arnebiae (Radix Lithospermi) 7, Oleum sesami 1000, Cera Flava 60, the invention of preparation technology's cost of manufacture gets final product routinely.
Preparation technology of the present invention and the technical finesse of not describing in detail partly are known technology.
Claims (6)
1, treatment psoriasis ointment is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 2-8, Radix Angelicae Dahuricae 3-10, Flos Carthami 3-12, Cortex Dictamni 2-6, Rhizoma Chuanxiong 2-10, Folium Isatidis 2-10, Cortex Acanthopancis 2-8, Radix Rehmanniae Preparata 2-8, Radix Cynanchi Paniculati 1-8, Radix Arnebiae (Radix Lithospermi) 3-12, Oleum sesami 500-1500, Cera Flava 20-100.
2, treatment psoriasis ointment according to claim 1 is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 3-7, Radix Angelicae Dahuricae 4-9, Flos Carthami 4-10, Cortex Dictamni 2.5-5.5, Rhizoma Chuanxiong 3-9, Folium Isatidis 3-9, Cortex Acanthopancis 3-7, Radix Rehmanniae Preparata 3-7, Radix Cynanchi Paniculati 2-7, Radix Arnebiae (Radix Lithospermi) 4-10, Oleum sesami 700-1400, Cera Flava 30-80.
3, treatment psoriasis ointment according to claim 1 is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 3.5-6.5, Radix Angelicae Dahuricae 4.5-8, Flos Carthami 5-9, Cortex Dictamni 3-5, Rhizoma Chuanxiong 4-8, Folium Isatidis 4-8, Cortex Acanthopancis 3.5-6.5, Radix Rehmanniae Preparata 3.5-6.5, Radix Cynanchi Paniculati 3-6, Radix Arnebiae (Radix Lithospermi) 5-8, Oleum sesami 800-1300, Cera Flava 40-70.
4, treatment psoriasis ointment according to claim 1 is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 4-6, Radix Angelicae Dahuricae 5-7, Flos Carthami 6-8, Cortex Dictamni 3.5-4.5, Rhizoma Chuanxiong 5-7, Folium Isatidis 5-7, Cortex Acanthopancis 4-6, Radix Rehmanniae Preparata 4-6, Radix Cynanchi Paniculati 3-5, Radix Arnebiae (Radix Lithospermi) 6-8, Oleum sesami 900-1100, Cera Flava 50-65.
5, treatment psoriasis ointment according to claim 1 is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 4.5-5.5, Radix Angelicae Dahuricae 5.5-6.5, Flos Carthami 6.5-7.5, Cortex Dictamni 3.8-4.2, Rhizoma Chuanxiong 5.5-6.5, Folium Isatidis 5.5-6.5, Cortex Acanthopancis 4.5-5.5, Radix Rehmanniae Preparata 4.5-5.5, Radix Cynanchi Paniculati 3.5-4.5, Radix Arnebiae (Radix Lithospermi) 6.5-7.5, Oleum sesami 950-1050, Cera Flava 55-62.
6, treatment psoriasis ointment according to claim 1 is characterized in that it comprises following component (in weight portion): Radix Angelicae Sinensis 5, the Radix Angelicae Dahuricae 6, Flos Carthami 7, Cortex Dictamni 4, Rhizoma Chuanxiong 6, Folium Isatidis 6, Cortex Acanthopancis 5, Radix Rehmanniae Preparata 5, Radix Cynanchi Paniculati 4, Radix Arnebiae (Radix Lithospermi) 7, Oleum sesami 1000, Cera Flava 60.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310105503 CN1233391C (en) | 2003-11-11 | 2003-11-11 | Psoriasis treating ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310105503 CN1233391C (en) | 2003-11-11 | 2003-11-11 | Psoriasis treating ointment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1543995A true CN1543995A (en) | 2004-11-10 |
| CN1233391C CN1233391C (en) | 2005-12-28 |
Family
ID=34333776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200310105503 Expired - Fee Related CN1233391C (en) | 2003-11-11 | 2003-11-11 | Psoriasis treating ointment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1233391C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100358544C (en) * | 2005-11-22 | 2008-01-02 | 温敬远 | Medicine for treating psoriasis |
| CN102727836A (en) * | 2012-07-23 | 2012-10-17 | 太仓市伟基生物科技有限公司 | Psoriasis anoint for external use |
| CN104800269A (en) * | 2015-05-19 | 2015-07-29 | 北京市中医研究所 | Traditional Chinese medicine external-use cream used for treating psoriasis and preparation method thereof |
| WO2020091703A1 (en) * | 2018-11-01 | 2020-05-07 | Yeditepe Universitesi | A medicine for treatment of psoriasis and production method thereof |
| RU2785038C2 (en) * | 2018-11-01 | 2022-12-02 | Едитепе Университеси | Drug for treatment of psoriasis and its production method |
-
2003
- 2003-11-11 CN CN 200310105503 patent/CN1233391C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100358544C (en) * | 2005-11-22 | 2008-01-02 | 温敬远 | Medicine for treating psoriasis |
| CN102727836A (en) * | 2012-07-23 | 2012-10-17 | 太仓市伟基生物科技有限公司 | Psoriasis anoint for external use |
| CN104800269A (en) * | 2015-05-19 | 2015-07-29 | 北京市中医研究所 | Traditional Chinese medicine external-use cream used for treating psoriasis and preparation method thereof |
| CN104800269B (en) * | 2015-05-19 | 2018-04-24 | 北京市中医研究所 | A kind of Chinese medicine external emulsifiable paste for treating psoriasis and preparation method thereof |
| WO2020091703A1 (en) * | 2018-11-01 | 2020-05-07 | Yeditepe Universitesi | A medicine for treatment of psoriasis and production method thereof |
| JP2022505933A (en) * | 2018-11-01 | 2022-01-14 | イェディテペ・ウニヴェルシテシ | Pharmaceuticals for the treatment of psoriasis and their manufacturing methods |
| RU2785038C2 (en) * | 2018-11-01 | 2022-12-02 | Едитепе Университеси | Drug for treatment of psoriasis and its production method |
| JP7377562B2 (en) | 2018-11-01 | 2023-11-10 | イェディテペ・ウニヴェルシテシ | Medicine for the treatment of psoriasis and its manufacturing method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1233391C (en) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101161273B (en) | A Chinese patent medicine for treating catagmat | |
| CN1333025A (en) | Medicine for treating bone injury | |
| CN108403911A (en) | A kind of medicinal liquor for treating traumatic injury | |
| CN101919927B (en) | Spray for promoting scald healing | |
| CN100534511C (en) | Combined Chinese-Western medicine mixture for treating mycotic skin disease, and its use method | |
| CN1435192A (en) | Jianzhoukang medicine for medicinal pillow for treating periomethritis and preparing method thereof | |
| CN1326550C (en) | Quick acting analgetic Chinese medicine liquid | |
| CN1233391C (en) | Psoriasis treating ointment | |
| CN1478526A (en) | Pure medicinal liquor | |
| CN102698214B (en) | Traditional Chinese medicine for treating migraine and preparation method thereof | |
| CN101057922A (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
| CN101214290B (en) | Powder for dispersing blood stasis | |
| CN1879749A (en) | Medicinal heath wine | |
| CN1110309C (en) | Medicine for treating psoriasis and preparation method thereof | |
| CN101439151B (en) | Medicament for treating beriberi | |
| CN102698148B (en) | Chinese medicinal patch for treating acute headache and preparation method thereof | |
| CN1100954A (en) | pearl powder for curing bedsore | |
| CN102641409B (en) | Traditional Chinese medicine for treating onychomycosis | |
| CN108175848B (en) | Traditional Chinese medicine composition for treating arthralgia and myalgia, plaster containing traditional Chinese medicine composition and preparation method | |
| CN1424077A (en) | External used medicine for psoriasis | |
| CN101249140A (en) | Hair growth agent and method of preparing the same | |
| CN105920538A (en) | Traditional Chinese medicinal composition for treating bone injuries and acute and chronic soft tissue injuries | |
| CN101062224A (en) | Chinese traditional medicine for treating chronic cholecystitis | |
| CN1190232C (en) | Wart-removing ointment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051228 Termination date: 20131111 |